Archives

Read More

This article was originally published on MedTech Intelligence  China In China, where the vast medical device market was valued at more than $40 billion in 2019, authorities have moved to secure the safety and efficacy of medical devices while at the same... Read More

Aging populations and increased incidences of chronic diseases across the Asia-Pacific region are spurring rapid growth in demand for in-vitro diagnostic (IVD) testing. That presents major marketing opportunities for the diagnostics industry in China, India, Southeast Asia, Japan, South Korea, and Indonesia.  ... Read More

The COVID-19 pandemic is hampering the initiation and progress of clinical trials in Asia and around the world. Few patients are entering studies, and trials of new treatments are on hold.   In Korea, the number of new patients enrolling in clinical... Read More

Medical device manufacturers marketing their products in Malaysia will be required to report to government authorities any events related to their use that could negatively impact patient’s health, under a Medical Device Authority regulation that went into effect on July 1. The... Read More

This article was originally published on MedTech Intelligence. With the COVID-19 pandemic shuttering physician offices and walk-in clinics, patients and doctors across Asian markets have turned increasingly to telehealth solutions. The surge is creating a short-term boom—and the likelihood of a long-term... Read More

https://attendee.gotowebinar.com/recording/5890292005019691021 Read More

This article was originally published on MedTech Intelligence. Led by Chinese Internet commerce giants Tencent and Alibaba, internet providers have been offering a vast array of cloud computing services free to researchers and clinicians, while hiking their investment in advanced technologies, since... Read More

Under draft classification guidance released by Malaysian health regulators, in vitro diagnostics tests on blood, tissue and other samples in Malaysia would be separated into four categories based on the risk they pose to consumers. The new draft regulations were released in... Read More

As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More